Free Trial
→ You’re Being LIED To About The Iran War (From Banyan Hill Publishing) (Ad)tc pixel Free EPRX Stock Alerts

Eupraxia Pharmaceuticals (EPRX) Institutional Ownership

Eupraxia Pharmaceuticals logo
$7.45 -0.02 (-0.27%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$7.70 +0.25 (+3.36%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Eupraxia Pharmaceuticals (NASDAQ:EPRX)

Number of
Institutional Buyers
(last 12 months)
27
Total
Institutional Inflows
(last 12 months)
$32.22M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$7.91M
Get EPRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eupraxia Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

EPRX Institutional Buying and Selling by Quarter

Eupraxia Pharmaceuticals Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026XTX Topco Ltd16,180$122K0.0%N/A0.045%
2/18/2026Ikarian Capital LLC610,000$4.61M0.4%N/A1.696%
2/18/2026Squadron Capital Management LLC500,000$3.78M1.6%N/A1.390%
2/18/2026SummitTX Capital L.P.175,948$1.33M0.0%N/A0.489%
2/18/2026Quadrature Capital Ltd43,186$326K0.0%N/A0.120%
2/18/2026Boothbay Fund Management LLC156,331$1.18M0.0%N/A0.435%
2/17/2026Ally Bridge Group NY LLC397,895$3.00M3.1%-56.5%1.106%
2/17/2026Guardian Wealth Advisors LLC NC10,000$76K0.0%N/A0.028%
2/17/2026Royal Bank of Canada196,277$1.48M0.0%-54.2%0.546%
2/16/2026Aptus Capital Advisors LLC10,000$76K0.0%N/A0.028%
2/13/2026Marshall Wace LLP158,133$1.19M0.0%N/A0.440%
2/13/2026Ingalls & Snyder LLC77,400$584K0.0%+31.0%0.215%
2/12/2026Jane Street Group LLC29,622$223K0.0%N/A0.082%
2/10/2026Cibc World Market Inc.58,050$437K0.0%+287.0%0.161%
2/10/2026Goldman Sachs Group Inc.58,058$438K0.0%+44.8%0.161%
2/9/2026Geode Capital Management LLC13,899$105K0.0%N/A0.039%
1/1/2026JPMorgan Chase & Co.16,467$97K0.0%-12.0%0.046%
11/17/2025Alyeska Investment Group L.P.250,000$1.48M0.0%N/A0.695%
11/17/2025Vivo Capital LLC1,350,000$7.97M0.6%N/A3.754%
11/17/2025Velan Capital Investment Management LP352,000$2.08M2.0%N/A0.979%
11/17/2025Integrated Wealth Concepts LLC12,000$71K0.0%N/A0.033%
11/17/2025Bank of America Corp DE45,577$269K0.0%+262.9%0.127%
11/17/2025Ally Bridge Group NY LLC915,000$5.40M3.3%N/A2.544%
11/14/2025Raymond James Financial Inc.33,373$197K0.0%+173.3%0.093%
11/14/2025Scotia Capital Inc.1,277,885$7.26M0.0%-1.1%3.554%
11/13/2025 UBS Group AG95,756$565K0.0%+155.4%0.266%
11/13/2025Guardian Partners Inc.24,130$147K0.0%N/A0.067%
11/7/2025Ingalls & Snyder LLC59,100$349K0.0%+58.9%0.164%
11/7/2025JPMorgan Chase & Co.16,467$97K0.0%-12.0%0.046%
10/14/2025 TCI Wealth Advisors Inc.11,000$65K0.0%N/A0.031%
8/15/2025Bank of America Corp DE12,559$72K0.0%+402.4%0.035%
8/13/2025Quadrature Capital Ltd10,700$61K0.0%N/A0.030%
8/13/2025Scotia Capital Inc.1,291,989$6.98M0.0%-16.8%3.593%
8/12/2025JPMorgan Chase & Co.18,717$108K0.0%+593.2%0.052%
8/11/2025TD Waterhouse Canada Inc.9,600$56K0.0%-90.9%0.027%
8/5/2025Bank of Montreal Can37,250$215K0.0%-28.7%0.104%
7/31/2025Ingalls & Snyder LLC37,200$214K0.0%N/A0.103%
5/15/2025Royal Bank of Canada342,828$1.13M0.0%+21.1%0.956%
5/9/2025Scotia Capital Inc.1,552,679$5.07M0.0%+11.6%4.331%
2/17/2025Millennium Management LLC10,000$31K0.0%N/A0.028%
2/13/2025Scotia Capital Inc.1,391,719$4.26M0.0%-0.3%3.907%
2/13/2025Raymond James Financial Inc.11,613$37K0.0%N/A0.033%
2/13/2025Bank of Montreal Can56,750$178K0.0%+15.2%0.159%
2/6/2025Raymond James Financial Inc.11,613$37K0.0%N/A0.033%
7/17/2024180 Wealth Advisors LLC13,000$34K0.0%N/A0.048%


EPRX Institutional Ownership - Frequently Asked Questions

During the previous two years, 31 institutional investors and hedge funds held shares of Eupraxia Pharmaceuticals. The most heavily invested institutionals were Vivo Capital LLC ($7.97M), Scotia Capital Inc. ($7.26M), Ikarian Capital LLC ($4.61M), Squadron Capital Management LLC ($3.78M), Ally Bridge Group NY LLC ($3.00M), Velan Capital Investment Management LP ($2.08M), and Royal Bank of Canada ($1.48M).Learn more on Eupraxia Pharmaceuticals' institutional investors.

Of the 30 institutional investors that purchased Eupraxia Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($1.35M), Ally Bridge Group NY LLC ($915K), Ikarian Capital LLC ($610K), Squadron Capital Management LLC ($500K), Velan Capital Investment Management LP ($352K), Alyeska Investment Group L.P. ($250K), and SummitTX Capital L.P. ($175.95K).

Institutional investors have bought a total of 5,145,692 shares in the last 24 months. This purchase volume represents approximately $32.74M in transactions.

The following institutional investors have sold Eupraxia Pharmaceuticals stock in the last 24 months: Ally Bridge Group NY LLC ($517.11K), Scotia Capital Inc. ($274.79K), Royal Bank of Canada ($232.53K), TD Waterhouse Canada Inc. ($95.39K), Bank of Montreal Can ($15K), and JPMorgan Chase & Co. ($4.50K).

Institutional investors have sold a total of 1,139,312 shares in the last 24 months. This volume of shares sold represents approximately $7.91M in transactions.


Related Companies

This page (NASDAQ:EPRX) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel